Skip to main content

Conflicts on HHS stem cell council

Nearly half the voting members of a Department of Health and Human Services linkurl:stem cell;https://www.the-scientist.com/article/display/54071/ advisory council have financial conflicts of interest despite the committee's pledge to limit these types of conflicts, according to a linkurl:survey;https://www.cspinet.org/integrity/watch/200804281.html#1 conducted by a science watchdog group. The Center for Science in the Public Interest polled the 25 voting members of HHS's linkurl:Advisory Council

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Nearly half the voting members of a Department of Health and Human Services linkurl:stem cell;https://www.the-scientist.com/article/display/54071/ advisory council have financial conflicts of interest despite the committee's pledge to limit these types of conflicts, according to a linkurl:survey;https://www.cspinet.org/integrity/watch/200804281.html#1 conducted by a science watchdog group. The Center for Science in the Public Interest polled the 25 voting members of HHS's linkurl:Advisory Council on Blood Stem Cell Transplantation;https://bloodcell.transplant.hrsa.gov/ABOUT/Advisory_Council/index.html (ACBSCT) and found that 11 reported having financial ties to stem cell and linkurl:umbilical cord blood;https://www.the-scientist.com/2007/03/01/s62/1/ banking companies, drug makers, and the linkurl:transplantation;https://www.the-scientist.com/article/display/17367/ industry. For example, linkurl:Frederick Appelbaum,;https://myprofile.cos.com/APPELBAUM who is the head of medical oncology at the University of Washington, has relationships with Merck, Bristol-Myers Squibb, Wyeth, and Genzyme. Another council member, linkurl:Richard Champlin,;https://www.mdanderson.org/departments/bmt/display.cfm?id=627c8063-8efd-11d4-80fa00508b603a14&method=displayfull&pn=d1766775-8e4c-11d4-80fa00508b603a14 is the chairman of the University of Texas in Houston's Stem Cell Transplantation and Cellular Therapy Department, but also serves on the medical advisory board of linkurl:Stemcyte,;https://www.the-scientist.com/article/display/15348/ an international company that runs cord blood banking programs. According to the Center for Science in the Public Interest, the HHS official in charge of the ACBSCT said that none of the initial applicants to the council (of which there were over 100) were screened for conflicts of interest even though the council's linkurl:charter;https://bloodcell.transplant.hrsa.gov/ABOUT/Advisory_Council/Charter/index.html clearly states that, "Any member of the Council who has an employment, governance, or financial affiliation with a donor center, recruitment organization, transplant center, or cord blood bank will be prohibited from participating in any decision that materially affects the donor center, recruitment organization, transplant center, or cord blood bank. The number of members with such affiliations on the Council shall be limited." The ACBSCT was formed in 2006 to advise HHS policy makers on cord blood donation and stem cell transplantation science and met for the first time this past January. The council is meeting today and tomorrow (Apr 28 and 29) in Rockville, Maryland to discuss cord blood donor recruitment practices, blood bank accreditation, and linkurl:stem cell transplantation;https://www.the-scientist.com/article/daily/24908/ practices.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad
Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

bioxcell
Scientist reviewing cellular and molecular data on a computer in a laboratory.

Building Translation-Ready Biomarkers with Connected Workflows

Danaher Logo

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays